Ligand Pharmaceuticals | LGND - Interest Income


Ligand Pharmaceuticals reported $3.87M in Interest Income for its fiscal quarter ending in September of 2025.





Interest Income Change Date
Arrowhead Research USD 9.05M 1.97M Sep/2025
Baxter International USD 10M 4M Sep/2025
Eli Lilly USD 65M 25M Sep/2025
Enviri Corporation USD -1.05 0.89 Dec/2024
Gilead Sciences USD 88M 15M Sep/2025
GlaxoSmithKline GBP 26M 24M Sep/2025
Glaxosmithkline GBP 26M 24M Sep/2025
Heron Therapeutics USD 433K 277K Dec/2021
Insmed USD 765K 55K Sep/2024
Intrexon USD 319K 602K Jun/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Ligand Pharmaceuticals USD 3.87M 2.25M Sep/2025
MacroGenics USD 1.53M 114K Sep/2025
Merck USD 96M 27M Sep/2025
Pacira USD 8.53M 3.53M Sep/2025
Pfizer USD 0.62 156M Sep/2025
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Veracyte USD 3.48M 545K Sep/2025